Just How Cognitive Is “Cognitive Enhancement”? On the Significance of Emotions in University Students’ Experiences with Study Drugs
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Numerous deliberations on the ethics of cognitive enhancement take as their primary case the nonmedical use of prescription stimulant drugs by university students seeking to improve their performance in relation to academic work. Almost without exception, such discussions suggest that these medications enable academic performance enhancement through effects on cognitive processes. This article reports findings from qualitative research with nonmedical users that indicate that stimulants' effects on users' emotions and feelings are an important contributor to users' perceptions of improved academic performance. On the basis of these findings, the article suggests the conceptualization of nonmedical use of stimulants in terms of "cognitive enhancement" may fail to adequately capture the perspectives and experiences of individuals who use stimulant drugs as study aids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2006) · Cited by 18,730
Handbook of Qualitative Research.
Fine, G. A., Denzin, N., & Lincoln, Y. (1995) · Contemporary Sociology · doi:10.2307/2076550 · Cited by 7,766
Local Knowledge: Further Essays In Interpretive Anthropology
Geertz, C. (1983) · Cited by 6,967
Constructing grounded theory. A practical guide through qualitative analysis
Brink, E., Dellve, L., Hallberg, U., Abrahamsson, K. H., Klingberg, G., & Wentz, K. (2006) · International Journal of Qualitative Studies on Health and Well-being · doi:10.3402/qhw.v1i3.4932 · Cited by 6,862
Descartes’ Error. Emotion, Reason and the Human Brain. New York (Grosset/Putnam) 1994.
Damasio, A. R. (1994) · Cited by 5,739
Qualitative Data Analysis with NVivo
Bazeley, P., & Jackson, K. (2007) · Cited by 2,522
Our posthuman future: consequences of the biotechnology revolution
(2002) · Choice Reviews Online · doi:10.5860/choice.40-0873 · Cited by 1,790
Cognitive Neuroscience of Emotion
(1999) · doi:10.1093/oso/9780195118889.001.0001 · Cited by 1,278
The man of reason: "male" and "female" in Western philosophy
Lloyd, G. E. R. (1984) · Medical Entomology and Zoology · Cited by 1,088
McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.00944.x · Cited by 884 · cited 2×
“, DeSantis, Noar, and Webb 2009; Keane 2008; Racine and Forlini 2010), most existing considerations of social and ethical dimensions of academic performance enhancement are based on two areas of research: survey research, especially about demographic patterns and public attitudes (e.g., Hotze et al. 2011; Maher 2008;…”
BackgroundTowards responsible use of cognitive-enhancing drugs by the healthy
Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzaniga, M., Campbell, P., & Farah, M. J. (2008) · Nature · doi:10.1038/456702a · Cited by 862 · cited 1×
“Such issues have received a good deal of attention from bioethicists, scientists, and others (Chatterjee 2009; Farah et al. 2004; Greely et al. 2008; Harris 2009; Hyman 2011; Outram 2010), who have noted that the use of academic performance-enhancing pharmaceuticals is a significant issue not only for university stude…”
BackgroundBeyond therapy: biotechnology and the pursuit of happiness
(2004) · Choice Reviews Online · doi:10.5860/choice.42-1550 · Cited by 703
Neurocognitive enhancement: what can we do and what should we do?
Farah, M. J., Illes, J., Cook-Deegan, R., Gardner, H., Kandel, E., King, P., Parens, E., Sahakian, B., & Wolpe, P. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1390 · Cited by 658 · cited 2×
“Such issues have received a good deal of attention from bioethicists, scientists, and others (Chatterjee 2009; Farah et al. 2004; Greely et al. 2008; Harris 2009; Hyman 2011; Outram 2010), who have noted that the use of academic performance-enhancing pharmaceuticals is a significant issue not only…”
The Cognitive Neuroscience of Emotion
Watt, D. F. (2001) · Neuropsychoanalysis · doi:10.1080/15294145.2001.10773346 · Cited by 608
Krämer, P. (1993) · Medical Entomology and Zoology · Cited by 578
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review
Repantis, D., Schlattmann, P., Laisney, O., & Heuser, I. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.04.002 · Cited by 576
Qualitative Data Analysis with NVivo
LAKEMAN, R. (2008) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2008.01257.x · Cited by 550
Teter, C. J., McCabe, S. E., LaGrange, K., Cranford, J. A., & Boyd, C. J. (2006) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.10.1501 · Cited by 540 · cited 1×
“, DeSantis, Noar, and Webb 2009; Keane 2008; Racine and Forlini 2010), most existing considerations of social and ethical dimensions of academic performance enhancement are based on two areas of research: survey research, especially about demographic patterns and public attitudes (e.g., Hotze et al. 2011; Maher 2008;…”
BackgroundPharmaceuticalization of Society in Context: Theoretical, Empirical and Health Dimensions
Abraham, J. (2010) · Sociology · doi:10.1177/0038038510369368 · Cited by 480 · cited 1×
“Such practices are part of a broader trend that has been noted by a range of scholars: Today, in societies of the West, pharmaceuticals are not only being prescribed and consumed to an unprecedented extent as treatments for mental illnesses, disturbances, and disabilities (Abraham 2010; Rose 2006; Wolf-Meyer 2009); th…”
Background(1994) · Cited by 459
Smith, M. E., & Farah, M. J. (2011) · Psychological Bulletin · doi:10.1037/a0023825 · Cited by 440
Enhancing human traits: ethical and social implications
(1999) · Choice Reviews Online · doi:10.5860/choice.36-4517 · Cited by 426 · cited 1×
“Such practices are part of a broader trend that has been noted by a range of scholars: Today, in societies of the West, pharmaceuticals are not only being prescribed and consumed to an unprecedented extent as treatments for mental illnesses, disturbances, and disabilities (Abraham 2010; Rose 2006; Wolf-Meyer 2009); th…”
BackgroundPoll results: look who's doping
Maher, B. (2008) · Nature · doi:10.1038/452674a · Cited by 417 · cited 2×
“, DeSantis, Noar, and Webb 2009; Keane 2008; Racine and Forlini 2010), most existing considerations of social and ethical dimensions of academic performance enhancement are based on two areas of research: survey research, especially about demographic patterns and public attitudes (e.g., Hotze et al. 2011; Maher 2008;…”
BackgroundSahakian, B., & Morein-Zamir, S. (2007) · Nature · doi:10.1038/4501157a · Cited by 326
Bourdieu, P. (1990) · Cultural Anthropology · doi:10.1525/can.1990.5.4.02a00030 · Cited by 271
Enhancing human traits : ethical and social implications
Parens, E. (1998) · Cited by 258
Volkow, N. D., Wang, G.-J., Tomasi, D., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F. W., Fowler, J. S., Logan, J., Wong, C. T., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4461-11.2012 · Cited by 237
Cakic, V (2009) · Journal of Medical Ethics · doi:10.1136/jme.2009.030882 · Cited by 195
Treatment, enhancement, and the ethics of neurotherapeutics
Wolpe, P. R. (2002) · Brain and Cognition · doi:10.1016/s0278-2626(02)00534-1 · Cited by 192 · cited 1×
“Such practices are part of a broader trend that has been noted by a range of scholars: Today, in societies of the West, pharmaceuticals are not only being prescribed and consumed to an unprecedented extent as treatments for mental illnesses, disturbances, and disabilities (Abraham 2010; Rose 2006; Wolf-Meyer 2009); th…”
BackgroundOn speed: the many lives of amphetamine
(2008) · Choice Reviews Online · doi:10.5860/choice.46-2125 · Cited by 177
Arria, A. M., O'Grady, K. E., Caldeira, K. M., Vincent, K. B., & Wish, E. D. (2008) · Journal of Drug Issues · doi:10.1177/002204260803800406 · Cited by 172 · cited 1×
“This trend, observed in both the United States and the United Kingdom but more pronounced in the former (Arria 2008; Maher 2008; McCabe et al. 2005; Sharp 2009), raises a number of social, ethical, and policymaking issues, such as whether pharmaceutical enhancement constitutes a form of cheating; whether the use of pr…”
BackgroundThe use of methylphenidate among students: the future of enhancement?
Outram, S. M. (2010) · Journal of Medical Ethics · doi:10.1136/jme.2009.034421 · Cited by 157 · cited 1×
“Such issues have received a good deal of attention from bioethicists, scientists, and others (Chatterjee 2009; Farah et al. 2004; Greely et al. 2008; Harris 2009; Hyman 2011; Outram 2010), who have noted that the use of academic performance-enhancing pharmaceuticals is a significant issue not only for university stude…”
BackgroundRacine, É., & Forlini, C. (2008) · Neuroethics · doi:10.1007/s12152-008-9023-7 · Cited by 129
Neuroenhancement in Young People: Proposal for Research, Policy, and Clinical Management
Singh, I., & Kelleher, K. J. (2010) · AJOB Neuroscience · doi:10.1080/21507740903508591 · Cited by 120
Deflating the Neuroenhancement Bubble
Lucke, J. C., Bell, S., Partridge, B., & Hall, W. (2011) · AJOB Neuroscience · doi:10.1080/21507740.2011.611122 · Cited by 100 · cited 1×
“However, the results reported here do appear entirely consonant with a range of scientific and social research, including: (1) reviews of clinical research indicating that stimulant drugs’ abilities to improve performance on cognitive tests may be quite limited (Lucke et al. 2011; Smith and Farah 2011); (2) pharmacolo…”
ResultCooper, C. L. (2010) · Stress and Health · doi:10.1002/smi.1307 · Cited by 94
Nonmedical ADHD Stimulant Use in Fraternities
DeSantis, A., Noar, S. M., & Webb, E. M. (2009) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2009.70.952 · Cited by 80
Hotze, T. D., Shah, K. R., Anderson, E. E., & Wynia, M. K. (2011) · The American Journal of Bioethics · doi:10.1080/15265161.2011.534957 · Cited by 76
Cognitive Enhancement: Promises and Perils
Hyman, S. E. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.012 · Cited by 70 · cited 1×
“Such issues have received a good deal of attention from bioethicists, scientists, and others (Chatterjee 2009; Farah et al. 2004; Greely et al. 2008; Harris 2009; Hyman 2011; Outram 2010), who have noted that the use of academic performance-enhancing pharmaceuticals is a significant issue not only for university stude…”
BackgroundWhen the boss turns pusher: a proposal for employee protections in the age of cosmetic neurology
Appel, J. (2008) · Journal of Medical Ethics · doi:10.1136/jme.2007.022723 · Cited by 68 · cited 1×
“2009), for governments and drug regulators (Cooper, Goswami, and Sahakian 2009; Fukuyama 2003; President’s Council on Bioethics 2003), and for the general public (Appel 2008; Gebhardt 2005).”
BackgroundPleasure and discipline in the uses of Ritalin
Keane, H. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2007.08.002 · Cited by 61 · cited 2×
“2012); and (3) the well-established potential for prescription stimulants to produce euphoric effects (DeSantis, Noar, and Webb 2009; Keane 2008; Racine and Forlini 2010; Rasmussen 2008).”
BackgroundQuintero, G., & Nichter, M. (2011) · Wiley eBooks · doi:10.1002/9781444395303.ch17 · Cited by 48
The Neurocognitive Enhancement of Surgeons: An Ethical Perspective
Warren, O. J., Leff, D. R., Athanasiou, T., Kennard, C., & Darzi, A. W. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2007.12.761 · Cited by 43
Is it acceptable for people to take methylphenidate to enhance performance? Yes
Harris, J. (2009) · BMJ · doi:10.1136/bmj.b1955 · Cited by 35 · cited 1×
“Such issues have received a good deal of attention from bioethicists, scientists, and others (Chatterjee 2009; Farah et al. 2004; Greely et al. 2008; Harris 2009; Hyman 2011; Outram 2010), who have noted that the use of academic performance-enhancing pharmaceuticals is a significant issue not only for university stude…”
BackgroundBrignell, C. M., Rosenthal, J., & Curran, H. V. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077351 · Cited by 33
Is it acceptable for people to take methylphenidate to enhance performance? No
Chatterjee, A. K. (2009) · BMJ · doi:10.1136/bmj.b1956 · Cited by 26
Wolf‐Meyer, M. (2009) · Medical Anthropology · doi:10.1080/01459740802640529 · Cited by 15 · cited 1×
“Such practices are part of a broader trend that has been noted by a range of scholars: Today, in societies of the West, pharmaceuticals are not only being prescribed and consumed to an unprecedented extent as treatments for mental illnesses, disturbances, and disabilities (Abraham 2010; Rose 2006; Wolf-Meyer 2009); th…”
BackgroundBetter Than Prozac: Creating the Next Generation of Psychiatric Drugs
Snyder, S. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1896 · Cited by 12
Special issue on cognitive enhancers
Robbins, T. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1389-z · Cited by 9
Cited by
The unknowns of cognitive enhancement
Farah, M. J. (2015) · Science · doi:10.1126/science.aad5893 · Cited by 115
“In a report entitled “Just How Cognitive is ‘Cognitive Enhancement’?” sociologist Scott Vrecko interviewed students who used Adderall and found that they emphasized motivational and mood effects as reasons for using the drugs for schoolwork (6).”
BackgroundEnhancement stimulants: perceived motivational and cognitive advantages
Ilieva, I. P., & Farah, M. J. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00198 · Cited by 72
“…laboratory evidence suggests that amphetamine and methylphenidate enhance motivation-related processes in healthy participants, and the in-depth interviewing conducted by Vrecko (2013) indicates that enhancement users find the motivational effects of these drugs helpful for enhancing schoolwork.”
BackgroundStimulants, cognition and ADHD
Baroni, A., & Castellanos, F. X. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.04.010 · Cited by 14
“In a qualitative study of stimulant use in college, Vrecko [41] identified several emotional and motivational domains associated with nonmedical stimulant use by college students.”
BackgroundInfluential
Metadata
- Authors
- Vrecko, S.
- Venue
- AJOB Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2013-01
- Volume
- 4
- Issue
- 1
- Pages
- 4-12
- ISSN
- 2150-7740 (ISSN-L)
- 2150-7759
- OpenAlex
- W2078909607
- Cited by
- 174
- References
- 49
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.